Mirati Therapeutics (MRTX) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Mirati Therapeutics (MRTX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 29, 2024 (07:09)

Sector: Healthcare

The share price of Mirati Therapeutics, Inc. (MRTX) now

Latest session on the 23rd of January for
Mirati Therapeutics, Inc. is negative
Trading Volume: 0
Open: 58.7 /  High: 58.7 /  Low: 58.7
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Mirati Therapeutics stocks, the 50-day moving average is the support level today.

For Mirati Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Mirati Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mirati Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Mirati Therapeutics share be worth in 2024 - 2028?

When should I take profit in Mirati Therapeutics stock? When should I record a loss on Mirati Therapeutics stock? What are analysts' forecasts for Mirati Therapeutics stock? What is the future of Mirati Therapeutics stock? We forecast Mirati Therapeutics stock performance using neural networks based on historical data on Mirati Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Mirati Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mirati Therapeutics shares. This happens once a day.


Historical and forecast chart of Mirati Therapeutics stock

The chart below shows the historical price of Mirati Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Mirati Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is focused on developing a pipeline of targeted cancer drugs. The company is developing candidate products to combat genetic and immunological cancer promoters. Its clinical programs consist of two candidate products: MRTX849, a Kirsten rat sarcoma inhibitor (KRAS) G12C, and Sitravatinib, a multi-kinase inhibitor. His KRAS inhibitor program is focused on the discovery and development of small molecule compounds that target KRAS G12C and G12D. MRTX849 is designed to inhibit the KRAS G12C mutations that are present in patients with non-small cell lung cancer (NSCLC), adenocarcinoma, colorectal cancer (CRC), pancreatic cancer, and several other intractable cancers. Sitravatinib is a spectrally selective kinase inhibitor designed to inhibit receptor tyrosine kinases (RTKs) including TAM family receptors (TYRO3, Axl, Mer), split family receptors (VEGFR2, KIT) and RET.

Mirati Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 31 60.51 59.88 61.40 2.55
Apr 01 60.51 58.86 61.25 4.07
Apr 02 59.88 58.87 61.28 4.09
Apr 03 60.23 58.84 60.76 3.26
Apr 04 61.31 60.62 63.02 3.96
Apr 05 61.24 59.98 62.72 4.57
Apr 06 60.75 59.67 62.11 4.10
Apr 07 61.13 59.76 62.63 4.80
Apr 08 63.27 61.54 64.89 5.43
Apr 09 63.14 62.32 64.80 3.97
Apr 10 62.70 61.95 63.27 2.13
Apr 11 62.83 61.60 63.77 3.53
Apr 12 64.61 62.80 65.18 3.78
Apr 13 64.84 63.70 66.11 3.78
Apr 14 63.70 61.98 64.86 4.64
Apr 15 65.49 64.45 67.02 3.98
Apr 16 65.85 64.15 66.96 4.38
Apr 17 67.26 65.89 68.18 3.47
Apr 18 65.19 63.57 66.94 5.31
Apr 19 65.64 64.88 67.34 3.79
Apr 20 66.33 64.99 68.05 4.72
Apr 21 65.45 63.75 66.16 3.77
Apr 22 65.77 65.26 67.04 2.72
Apr 23 65.66 64.83 66.55 2.66
Apr 24 66.97 65.30 68.18 4.41
Apr 25 68.49 67.24 69.66 3.60
Apr 26 66.93 66.32 68.01 2.54
Apr 27 67.19 65.73 68.41 4.08
Apr 28 68.32 67.46 68.91 2.16
Apr 29 69.37 68.47 70.22 2.55

Mirati Therapeutics Daily Price Targets


Mirati Therapeutics Stock Forecast 03-31-2024.

Forecast target price for 03-31-2024: $60.51.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.484%.
Pessimistic target level: 59.88
Optimistic target level: 61.40

Mirati Therapeutics Stock Forecast 04-01-2024.

Forecast target price for 04-01-2024: $60.51.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.907%.
Pessimistic target level: 58.86
Optimistic target level: 61.25

Mirati Therapeutics Stock Forecast 04-02-2024.

Forecast target price for 04-02-2024: $59.88.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.933%.
Pessimistic target level: 58.87
Optimistic target level: 61.28

Mirati Therapeutics Stock Forecast 04-03-2024.

Forecast target price for 04-03-2024: $60.23.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.157%.
Pessimistic target level: 58.84
Optimistic target level: 60.76

Mirati Therapeutics Stock Forecast 04-04-2024.

Forecast target price for 04-04-2024: $61.31.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.813%.
Pessimistic target level: 60.62
Optimistic target level: 63.02

Mirati Therapeutics Stock Forecast 04-05-2024.

Forecast target price for 04-05-2024: $61.24.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 4.374%.
Pessimistic target level: 59.98
Optimistic target level: 62.72

MRTX (MRTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 64.25 56.63 70.99 20.23
May. 70.51 66.39 72.84 8.86
Jun. 72.73 64.11 75.35 14.91
Jul. 71.21 65.22 75.90 14.07
Aug. 73.34 66.74 77.41 13.79
Sep. 77.41 70.91 82.29 13.83
Oct. 87.28 80.34 96.32 16.58
Nov. 89.77 79.67 100.14 20.44
Dec. 88.02 83.66 94.36 11.33

Mirati Therapeutics forecast for this year


Mirati Therapeutics Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $64.2471. Pessimistic: $56.63. Optimistic: $70.99


Mirati Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $70.5112. Pessimistic: $66.39. Optimistic: $72.84


Mirati Therapeutics Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $72.7324. Pessimistic: $64.11. Optimistic: $75.35


Mirati Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $71.205. Pessimistic: $65.22. Optimistic: $75.90


Mirati Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $73.3411. Pessimistic: $66.74. Optimistic: $77.41


Mirati Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $77.4116. Pessimistic: $70.91. Optimistic: $82.29


Mirati Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $87.2815. Pessimistic: $80.34. Optimistic: $96.32


Mirati Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $89.7691. Pessimistic: $79.67. Optimistic: $100.14


Mirati Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $88.0186. Pessimistic: $83.66. Optimistic: $94.36



Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 78.78 75.11 87.05 13.71
Feb 70.62 64.37 77.30 16.72
Mar 71.26 69.12 74.04 6.64
Apr 80.24 76.63 83.73 8.48
May 83.61 73.83 91.88 19.65
Jun 83.36 79.61 90.86 12.39
Jul 77.61 73.41 84.71 13.33
Aug 83.66 75.63 86.80 12.87
Sep 85.42 77.34 90.41 14.45
Oct 89.64 86.01 95.56 9.99
Nov 86.95 78.21 89.56 12.67
Dec 78.61 74.83 83.68 10.57

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 81.32 74.85 86.56 13.53
Feb 76.56 73.69 84.83 13.13
Mar 80.35 74.32 89.99 17.41
Apr 74.81 67.74 83.00 18.39
May 82.55 77.47 88.49 12.45
Jun 76.48 71.32 82.22 13.26
Jul 78.20 75.86 83.72 9.39
Aug 75.15 70.31 79.32 11.37
Sep 79.77 70.32 88.87 20.87
Oct 72.59 64.97 75.43 13.86
Nov 79.35 74.94 83.63 10.39
Dec 79.23 72.33 87.90 17.71

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 84.93 76.01 95.00 19.98
Feb 93.72 88.38 98.64 10.40
Mar 100.89 93.32 105.13 11.23
Apr 95.75 88.85 102.07 12.95
May 100.20 89.68 111.92 19.88
Jun 97.64 92.08 102.33 10.02
Jul 90.03 83.82 100.56 16.65
Aug 82.46 79.13 91.37 13.40
Sep 77.39 73.68 82.04 10.19
Oct 80.99 71.39 89.86 20.55
Nov 75.65 70.54 78.82 10.51
Dec 74.28 68.83 79.74 13.69

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 85.43 81.71 95.17 14.14
Feb 95.55 89.24 107.02 16.61
Mar 103.29 91.21 108.56 15.98
Apr 106.70 103.18 114.54 9.92
May 101.10 91.70 106.71 14.07
Jun 97.91 92.48 107.02 13.59
Jul 88.07 83.05 90.98 8.71
Aug 85.83 78.62 95.35 17.55
Sep 82.87 78.39 87.34 10.25
Oct 78.89 76.52 86.82 11.86
Nov 74.98 71.05 78.02 8.94
Dec 85.11 76.94 92.00 16.37

Mirati Therapeutics information and performance

Mirati Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Mirati Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MRTX shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Mirati Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.